REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 183 filers reported holding REPLIGEN CORP in Q3 2016. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $616,000 | +2.0% | 20,000 | 0.0% | 0.41% | +97.6% |
| Q3 2016 | $604,000 | +10.4% | 20,000 | 0.0% | 0.21% | -5.9% |
| Q2 2016 | $547,000 | +2.1% | 20,000 | 0.0% | 0.22% | -1.8% |
| Q1 2016 | $536,000 | -5.3% | 20,000 | 0.0% | 0.22% | +40.3% |
| Q4 2015 | $566,000 | +1.6% | 20,000 | 0.0% | 0.16% | +48.6% |
| Q3 2015 | $557,000 | -97.0% | 20,000 | -95.6% | 0.11% | -94.0% |
| Q2 2015 | $18,852,000 | -11.0% | 456,800 | -34.5% | 1.78% | -11.2% |
| Q1 2015 | $21,179,000 | +50.6% | 697,600 | -1.8% | 2.00% | +48.4% |
| Q4 2014 | $14,060,000 | +1.6% | 710,100 | +2.2% | 1.35% | -5.6% |
| Q3 2014 | $13,839,000 | -17.4% | 695,100 | -5.4% | 1.43% | -0.7% |
| Q2 2014 | $16,748,000 | +78.2% | 734,900 | +0.5% | 1.44% | +87.2% |
| Q1 2014 | $9,401,000 | -7.0% | 731,000 | -1.3% | 0.77% | -7.4% |
| Q4 2013 | $10,107,000 | +174.3% | 741,000 | +123.1% | 0.83% | +141.0% |
| Q3 2013 | $3,684,000 | – | 332,200 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |